- Home
- COGT vs LDP Comparison
COGT vs LDP Comparison
Compare COGT & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- LDP
- Stock Information
- Founded
- COGT 2014
- LDP 2012
- Country
- COGT United States
- LDP United States
- Employees
- COGT N/A
- LDP N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- LDP Finance Companies
- Sector
- COGT Health Care
- LDP Finance
- Exchange
- COGT Nasdaq
- LDP Nasdaq
- Market Cap
- COGT 555.6M
- LDP 556.9M
- IPO Year
- COGT 2018
- LDP N/A
- Fundamental
- Price
- COGT $5.44
- LDP $20.40
- Analyst Decision
- COGT Buy
- LDP
- Analyst Count
- COGT 6
- LDP 0
- Target Price
- COGT $15.20
- LDP N/A
- AVG Volume (30 Days)
- COGT 1.2M
- LDP 102.5K
- Earning Date
- COGT 05-06-2025
- LDP 01-01-0001
- Dividend Yield
- COGT N/A
- LDP 7.91%
- EPS Growth
- COGT N/A
- LDP N/A
- EPS
- COGT N/A
- LDP N/A
- Revenue
- COGT N/A
- LDP N/A
- Revenue This Year
- COGT N/A
- LDP N/A
- Revenue Next Year
- COGT N/A
- LDP N/A
- P/E Ratio
- COGT N/A
- LDP N/A
- Revenue Growth
- COGT N/A
- LDP N/A
- 52 Week Low
- COGT $3.72
- LDP $16.16
- 52 Week High
- COGT $12.61
- LDP $20.30
- Technical
- Relative Strength Index (RSI)
- COGT 56.27
- LDP 61.76
- Support Level
- COGT $4.80
- LDP $20.20
- Resistance Level
- COGT $4.99
- LDP $20.56
- Average True Range (ATR)
- COGT 0.31
- LDP 0.18
- MACD
- COGT 0.07
- LDP 0.00
- Stochastic Oscillator
- COGT 88.56
- LDP 61.46
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.